Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms
Jessica Cassin, … , Pamela L. Mellon, Ravikumar Balasubramanian
Jessica Cassin, … , Pamela L. Mellon, Ravikumar Balasubramanian
Published January 5, 2023
Citation Information: JCI Insight. 2023;8(3):e164324. https://doi.org/10.1172/jci.insight.164324.
View: Text | PDF
Research Article Endocrinology Neuroscience

Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms

  • Text
  • PDF
Abstract

Pathogenic SRY-box transcription factor 2 (SOX2) variants typically cause severe ocular defects within a SOX2 disorder spectrum that includes hypogonadotropic hypogonadism. We examined exome-sequencing data from a large, well-phenotyped cohort of patients with idiopathic hypogonadotropic hypogonadism (IHH) for pathogenic SOX2 variants to investigate the underlying pathogenic SOX2 spectrum and its associated phenotypes. We identified 8 IHH individuals harboring heterozygous pathogenic SOX2 variants with variable ocular phenotypes. These variant proteins were tested in vitro to determine whether a causal relationship between IHH and SOX2 exists. We found that Sox2 was highly expressed in the hypothalamus of adult mice and colocalized with kisspeptin 1 (KISS1) expression in the anteroventral periventricular nucleus of adult female mice. In vitro, shRNA suppression of mouse SOX2 protein in Kiss-expressing cell lines increased the levels of human kisspeptin luciferase (hKiss-luc) transcription, while SOX2 overexpression repressed hKiss-luc transcription. Further, 4 of the identified SOX2 variants prevented this SOX2-mediated repression of hKiss-luc. Together, these data suggest that pathogenic SOX2 variants contribute to both anosmic and normosmic forms of IHH, attesting to hypothalamic defects in the SOX2 disorder spectrum. Our study describes potentially novel mechanisms contributing to SOX2-related disease and highlights the necessity of SOX2 screening in IHH genetic evaluation irrespective of associated ocular defects.

Authors

Jessica Cassin, Maria I. Stamou, Kimberly W. Keefe, Kaitlin E. Sung, Celine C. Bojo, Karen J. Tonsfeldt, Rebecca A. Rojas, Vanessa Ferreira Lopes, Lacey Plummer, Kathryn B. Salnikov, David L. Keefe Jr., Metin Ozata, Myron Genel, Neoklis A. Georgopoulos, Janet E. Hall, William F. Crowley Jr., Stephanie B. Seminara, Pamela L. Mellon, Ravikumar Balasubramanian

×

Figure 2

SOX2 is expressed in AVPV but not ARC kisspeptin neurons in adult mouse hypothalamus.

Options: View larger image (or click on image) Download as PowerPoint
SOX2 is expressed in AVPV but not ARC kisspeptin neurons in adult mouse ...
(A–C) Kiss-tdTomato (red), α-SOX2 (green), and DAPI (blue). White arrowheads identify cells in which Kiss-tdTomato and SOX2 are colocalized. Sections are from female AVPV, female ARC, and male ARC Kiss-tdTomato reporter mice, respectively. (D) Quantification of the percentage of SOX2 colocalized with Kiss-tdTomato. N = 3 mice. A minimum of 150 kisspeptin neurons were quantified per replicate. (E and F) Schematics of the location of kisspeptin neurons in the AVPV and ARC of mice, respectively. Kisspeptin neurons were quantified throughout both regions of the hypothalamus. Schematics depict relative position of representative images in A–C with regions highlighted in red. Original image taken at 20× magnification. Scale bar = 10 μm. Data represent mean ± SEM. Data were analyzed using 1-way ANOVA with Tukey’s multiple-comparison post hoc test. Significance indicated by ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts